These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13171379)

  • 1. Observations on the metabolic transformation and effects of phenylbutazone in subjects with hepatic disease.
    WEINER M; CHENKIN T; BURNS JJ
    Am J Med Sci; 1954 Jul; 228(1):36-9. PubMed ID: 13171379
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phenylbutazone and liver function; behavior of liver function in relation to treatment with phenylbutazone in normal and in liver disease].
    CHITI E; CAPPONI G
    Arch Maragliano Patol Clin; 1955 Jun; 10(3):1225-46. PubMed ID: 13269248
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatorenal lesions in the course of experimental ulcers caused by phenylbutazone in dogs; observations on the protective effects of gastrointestinal extracts].
    DASCALAKIS T; PAPACHARALAMBOUS N; CHRYSOSPATHIS P
    Arch Mal Appar Dig Mal Nutr; 1956; 45(1-2):116-25. PubMed ID: 13314779
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of the resorption if isopyrine and phenylbutazone after cutaneous application].
    Vogel J; Ache IM; Seyferth E
    Arzneimittelforschung; 1967 May; 17(5):640-2. PubMed ID: 5631597
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phenylbutazone and glycogen: effect of phenylbutazone therapy on the glycogen content of the liver, heart and muscles of normal rabbits of both sexes].
    CHITI E; ASTENGO F
    Arch Maragliano Patol Clin; 1955 Aug; 11(1):157-61. PubMed ID: 13276108
    [No Abstract]   [Full Text] [Related]  

  • 6. The metabolic fate of phenylbutazone (butazolidin) in man.
    BURNS JJ; ROSE RK; GOODWIN S; REICHENTHAL J; HORNING EC; BRODIE BB
    J Pharmacol Exp Ther; 1955 Apr; 113(4):481-9. PubMed ID: 14368518
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic necrosis and other visceral lesions associated with phenylbutazone therapy.
    MACCARTHY JM; JACKSON RT
    Br Med J; 1955 Jul; 2(4933):240-2. PubMed ID: 14389736
    [No Abstract]   [Full Text] [Related]  

  • 8. [Phenylbutazone and water-electrolyte metabolism; modifications of the electrolytes, sodium potassium and chlorine, after administration of phenylbutazone in normal subjects].
    CHITI E; MALERBA G
    Arch Maragliano Patol Clin; 1955 Jun; 10(3):1259-71. PubMed ID: 13269250
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver nucleic acid incorporation of phosphorus32 in rats injected with phenylbutazone.
    DELFEL NE; GRIFFIN AC
    Stanford Med Bull; 1953 Feb; 11(1):65-8. PubMed ID: 13056836
    [No Abstract]   [Full Text] [Related]  

  • 10. Application of clearance concepts to some literature data on drug metabolism in the isolated perfused liver preparation and in vivo.
    Rowland M
    Eur J Pharmacol; 1972 Mar; 17(3):352-6. PubMed ID: 5022150
    [No Abstract]   [Full Text] [Related]  

  • 11. Observations on the effects of intra-articular phenylbutazone.
    NEUSTADT DH; STEINBROCKER O
    J Lab Clin Med; 1956 Feb; 47(2):284-8. PubMed ID: 13295686
    [No Abstract]   [Full Text] [Related]  

  • 12. A STUDY OF STRUCTURE--ACTIVITY RELATIONSHIPS IN REGARD TO SPECIES DIFFERENCE IN THE PHENYLBUTAZONE SERIES.
    PEREL JM; SNELL MM; CHEN W; DAYTON PG
    Biochem Pharmacol; 1964 Sep; 13():1305-17. PubMed ID: 14221728
    [No Abstract]   [Full Text] [Related]  

  • 13. [Medicinal treatment of arthroses. Effects of oxyphenbutazone (Tanderil) compared with phenylbutazone (Butazolidin)].
    GJORUP L
    Ugeskr Laeger; 1963 Jun; 125():863-5. PubMed ID: 13948319
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metabolism of phenylbutazone in the liver (author's transl)].
    González Macías J; De Castro del Pozo S
    Med Klin; 1976 Sep; 71(36):1434-8. PubMed ID: 958107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phenylbutazone and ascorbic acid: effect of phenylbutazone on ascorbic acid content of the adrenal glands].
    CHITI E; ASTENGO F
    Arch Maragliano Patol Clin; 1955 Aug; 11(1):153-6. PubMed ID: 13276107
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phenylbutazone].
    GAUDIN G
    Rev Rhum Mal Osteoartic; 1956 Jan; 23(1):25-39. PubMed ID: 13311176
    [No Abstract]   [Full Text] [Related]  

  • 17. The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material.
    BURNS JJ; ROSE RK; CHENKIN T; GOLDMAN A; SCHULERT A; BRODIE BB
    J Pharmacol Exp Ther; 1953 Nov; 109(3):346-57. PubMed ID: 13109696
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental study of the effects of phenylbutazone on various allergic phenomena. I. Phenylbutazone and anaphylactic shock].
    TIGANO F
    G Batteriol Immunol; 1955; 48(3-4):134-48. PubMed ID: 13277770
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental study of the effects of phenylbutazone on various allergic phenomena. III. Phenylbutazone and Sanarelli-Shwartzmann phenomenon].
    TIGANO F
    G Batteriol Immunol; 1955; 48(3-4):157-63. PubMed ID: 13277772
    [No Abstract]   [Full Text] [Related]  

  • 20. Morphological changes in the liver due to phenazone and its derivatives.
    Altmann HW
    Agents Actions Suppl; 1986; 19():267-79. PubMed ID: 3463183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.